We serve Pregn-4-en-3-one, 21-hydroxy-20-methyl- CAS:60966-36-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White or almost white crystalline powder | Conform |
| Loss on drying | ≤0.5 % | 0.2% |
| Total impurities | ≤1.0 % | 0.45% |
| Purity | ≥99. 0% | 99.55% |
| Assay (HPLC) | ≥97.5% | 98.6% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like Pregn-4-en-3-one, 21-hydroxy-20-methyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pregn-4-en-3-one, 21-hydroxy-20-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pregn-4-en-3-one, 21-hydroxy-20-methyl- Use and application,Pregn-4-en-3-one, 21-hydroxy-20-methyl- technical grade,usp/ep/jp grade.
Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.2,4-dodecadienol manufacturer ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.2,2′-(Cocoimino)bisethanol with bis-(2-ethylhexyl) phosphate supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.diethyl 2-cycloheptylpropanedioate vendor Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.
